Home > Browse Research > Life Sciences > Pharmaceuticals > Therapeutic Area > Renal

Renal: market research reports

Find the information you need on the renal, kidney disease, dialysis and equipment industry. Our collection of research reports provides insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.

Renal market research reports and industry analysis

Kidney Dialysis Centers 5/13/2013 \| published by: First Research, Inc. ... Braun Melsungen. The US commercial kidney dialysis industry includes about 4,200 centers with combined annual revenue of about $16 billion. High growth is forecast for this industry for the next two years. Key drivers for ... \| read more...	$129.00
Renal Cancer Drug Pipeline Update 2013 4/22/2013 \| published by: BioSeeker Group AB ... existing cytokine therapy being less than 20% (RCC) in this patient cohort.The identification of biomarkers is set to revolutionize patient staging and prognosis by individualizing patient treatments and creating novel drug targets. There are today ... \| read more...	$5,621.25
The World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada ) 4/15/2013 \| published by: Kalorama Information ... industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment). The dialysis industry remains a robust, multi-billion dollar business that has managed to fuel its growth engine in the past 5 ... \| read more...	$3,995.00
Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H1 2013 4/10/2013 \| published by: Global Markets Direct ... provides information on the therapeutic development for Kidney Cancer (Renal Cell Cancer), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ... \| read more...	$2,000.00
Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Review, H1 2013 4/10/2013 \| published by: Global Markets Direct ... therapeutic pipeline. This report provides information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ... \| read more...	$2,000.00
Polycystic Kidney Disease – Pipeline Review, H1 2013 3/28/2013 \| published by: Global Markets Direct ... therapeutic development for Polycystic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Polycystic Kidney Disease. Polycystic Kidney Disease ... \| read more...	$2,000.00
Renal Failure – Pipeline Review, H1 2013 3/28/2013 \| published by: Global Markets Direct ... for Renal Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Renal Failure. Renal Failure - Pipeline Review, Half Year ... \| read more...	$2,000.00
Renal Cell Carcinoma – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... development for Renal Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Renal Cell Carcinoma. Renal Cell Carcinoma - ... \| read more...	$2,000.00
Global Kidney Cancer Drugs Market 2012-2016 3/11/2013 \| published by: Infiniti Research Limited ... in developing economies. The Global Kidney Cancer Drugs market has also been witnessing an increase in R&D activities. However, over-dependence of the market on the US could pose a challenge to the growth of this ... \| read more...	$2,000.00
Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... report provides information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic ... \| read more...	$2,000.00
Metastatic Renal Cell Carcinoma – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... the therapeutic development for Metastatic Renal Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Renal Cell Carcinoma. ... \| read more...	$2,000.00
Pipeline: Renal Cell Cancer 1/15/2013 \| published by: Datamonitor ... delay progression. As a consequence, effective treatment options capable of sustaining responses in RCC are still required. Features and benefits Our analysis of late-stage pipeline drugs will help you identify the most effective market entry ... \| read more...	$4,500.00
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... indication’s therapeutic pipeline. This report provides information on the therapeutic development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ... \| read more...	$2,000.00
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012 12/12/2012 \| published by: GlobalData ... Cancer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney Cancer (Renal Cell Cancer). It includes an overview of the trial numbers and their recruitment status as ... \| read more...	$2,500.00
Conference Documentation: Diabetes, Cardiovascular and Renal Complications 11/28/2012 \| published by: SMI Publishing, Ltd ... epidemic levels and will account for eight percent of the world’s adult population by 2030. As the number of diabetics grows, so will the need for new treatments to mitigate the effects on the vasculature ... \| read more...	$788.78
Kidney Dialysis Equipment And Supplies 11/1/2012 \| published by: Global Industry Analysts ... and Peritoneal Dialysis (PD) (Peritoneal Dialysis Cycler Machines, Peritoneal Tubing Kits, Dialysates, & Catheters). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual forecasts are ... \| read more...	$4,950.00
Renal Cancer Drug Pipeline Update 2012 10/16/2012 \| published by: BioSeeker Group AB ... (RCC) in this patient cohort.The identification of biomarkers is set to revolutionize patient staging and prognosis by individualizing patient treatments and creating novel drug targets. There are today 165 companies plus partners developing 200 drugs ... \| read more...	$2,264.00
Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 9/30/2012 \| published by: GlobalData ... information and analysis on the global renal dialysis equipment market. The report provides market landscape, competitive landscape and market trends information on the renal dialysis equipment market. The report provides comprehensive information on the key ... \| read more...	$3,995.00
Disease and Therapy Review: ESRD 9/28/2012 \| published by: Timely Data Resources, Inc. ... treatment with a focus on dialysis. Dosing and treatment cost information is provided for various treatment types and for medication associated with dialysis. General information on the ESRD market, as well as sales of leading ... \| read more...	$995.00
Chinese Markets for Kidney Cancer Treatment Drugs 9/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
R&D Trends: Renal Cell Cancer – Crowded RCC market remains attractive to drug developers 8/9/2012 \| published by: Datamonitor ... only delay progression. As a consequence, effective treatment options capable of sustaining responses in RCC are still needed. Scope In-depth analysis of renal cell cancer pipeline – development stage, therapeutic class, molecular targets, and changes ... \| read more...	$3,800.00
Global Renal Denervation Market Report: 2012 Edition 8/1/2012 \| published by: Koncept Analytics ... by managing the blood pressure, it suppresses the risk of occurrence of adverse events significantly. But, if it is left untreated, increases the risk of mortality from ischemic heart disease and stroke two folds. Renal ... \| read more...	$800.00
End-stage Renal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2019 6/30/2012 \| published by: GlobalData ... The report is an essential source of information and analysis on the global End Stage Renal Disease Therapeutics market. The report identifies the key trends shaping and driving the global End Stage Renal Disease Therapeutics ... \| read more...	$3,995.00
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2012 6/30/2012 \| published by: GlobalData ... Acute Renal Failure (ARF) (Acute Kidney Injury)/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury)/Impaired Glucose Tolerance. It includes ... \| read more...	$2,500.00
TreatmentTrends®: Chronic Kidney Disease (Wave 1) US 2012 6/29/2012 \| published by: Decision Resources ... key details on how U.S. patients in all Stages of Chronic Kidney Disease (CKD) are managed: early disease (Stage 1 and 2), mid-stage disease (Stage 3) and late-stage disease (Stage 4 and 5 not on ... \| read more...	$15,000.00

< prev 1 2 3 4 5 6 next >